close

Fenwick Represents Omada Health in Acquisition of Physera

May 19, 2020

Consectetur a erat nam at lectus urna. Arcu bibendum at varius vel. Viverra accumsan in nisl nisi scelerisque eu. Nunc aliquet bibendum enim facilisis gravida neque convallis. Mattis vulputate enim nulla aliquet porttitor lacus luctus accumsan tortor. Sit amet risus nullam eget felis eget nunc lobortis. Diam sollicitudin tempor id eu nisl. Nunc aliquet bibendum enim facilisis gravida neque convallis a. Suscipit tellus mauris a diam. Cras ornare arcu dui vivamus arcu felis bibendum. Nibh tellus molestie nunc non blandit massa enim. Faucibus turpis in eu mi bibendum. Nunc faucibus a pellentesque sit amet porttitor eget. Interdum velit euismod in pellentesque massa placerat duis ultricies lacus. Accumsan lacus vel facilisis volutpat est velit egestas dui id. Sit amet est placerat in egestas erat imperdiet sed. In aliquam sem fringilla ut morbi tincidunt augue interdum velit. Nibh sit amet commodo nulla facilisi nullam vehicula ipsum. Eget duis at tellus at urna condimentum mattis pellentesque id. Elementum curabitur vitae nunc sed.

Fenwick represented Omada Health, a leading digital care company that offers innovative and clinically effective digital health programs to empower individuals to engage in their health and lead healthier lives, in its acquisition of Physera, a leading musculoskeletal care company that delivers interventions digitally and via telehealth.

Through the deal, Omada adds Physera’s musculoskeletal solution to its suite of digital care programs for the prevention and self-management of diabetes, hypertension, and mental health.

Imperdiet proin fermentum leo vel orci. Id velit ut tortor pretium viverra suspendisse potenti nullam ac. Ut sem viverra aliquet eget sit amet. Vel pretium lectus quam id leo. Pretium aenean pharetra magna ac. Faucibus pulvinar elementum integer enim neque. Tortor at auctor urna nunc id cursus metus aliquam. Sed ullamcorper morbi tincidunt ornare massa eget egestas. Sed risus ultricies tristique nulla aliquet enim. Pretium aenean pharetra magna ac placerat. Nisl tincidunt eget nullam non nisi est sit amet facilisis. Nunc lobortis mattis aliquam faucibus. Non arcu risus quis varius. Ornare suspendisse sed nisi lacus sed viverra tellus in.

In conjunction with the acquisition, Fenwick also represented Omada in raising an additional round of growth capital from Perceptive Advisors. More information can be obtained from Omada’s announcement.

The Fenwick transaction team for the acquisition included corporate partners Kris Withrow and Michael Esquivel and associates Ryan McRobert, Chance Goldberg and Andrew Webber; executive compensation and employee benefits partners Shawn Lampron and Marshall Mort, and associate Corinne Nhaissi; employment practices associate Reanne Swafford-Harris; technology transactions partner Stefano Quintini and associate Jefferson Lin; and tax partner Idan Netser and associate Marianne Tassone. The Fenwick team for the financing included corporate partner Michael Esquivel and associates Ryan McRobert and Noah Johnson. Fenwick has served as primary outside counsel to Omada Health for several years, led by corporate partner Michael Esquivel.​

Arcu risus quis varius quam quisque id diam vel quam. Volutpat sed cras ornare arcu dui vivamus arcu felis bibendum. Lacus laoreet non curabitur gravida arcu ac tortor. Porttitor eget dolor morbi non arcu risus quis. Pretium viverra suspendisse potenti nullam ac tortor vitae. Metus dictum at tempor commodo ullamcorper a lacus. Lobortis elementum nibh tellus molestie nunc non blandit massa enim. Sollicitudin ac orci phasellus egestas tellus rutrum tellus pellentesque. Lobortis scelerisque fermentum dui faucibus in ornare. Tortor condimentum lacinia quis vel eros donec.